Baseline characteristics of patients in the Tranexamic acid for primary IntraCerebral Haemorrhage-2 (TICH-2) trial: an interim analysis

被引：0
|
作者：
Law, Z. K. [1 ,2 ]
Flaherty, K. [1 ]
Scutt, P. [1 ]
Appleton, J. P. [1 ]
Bath, P. M. [1 ]
Sprigg, N. [1 ]
机构：
[1] Univ Nottingham, Stroke Trials Unit, Nottingham, England
[2] Natl Univ Malaysia, Dept Med, Selangor, Malaysia
来源：
INTERNATIONAL JOURNAL OF STROKE | 2017年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
100
引用
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [1] Characteristics and Outcomes of Patients on Prior Antiplatelet Therapy in the Tranexamic Acid in Primary Intracerebral Haemorrhage-2 (TICH-2) Trial
    Law, Zhe Kang
    Flaherty, Katie
    Appleton, Jason P.
    Scutt, Polly
    Krishnan, Kailash
    Ali, Azlinawati
    Dineen, Rob
    Bath, Philip M.
    Sprigg, Nikola
    STROKE, 2018, 49
  • [2] TICH-2 Trial - tranexamic acid for intracerebral haemorrhage 2
    Sprigg, N.
    Bath, P. M. W.
    Krishnan, K.
    Foster, H.
    Payne, T.
    Adrian, M.
    Keeling, J.
    Howard, H.
    Stringer, M.
    Robson, K. S.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 432 - 432
  • [3] TICH-2 TRIAL - TRANEXAMIC ACID FOR INTRACEREBRAL HAEMORRHAGE 2
    Sprigg, N.
    Bath, P.
    Appleton, J.
    Foster, H.
    Adrian, M.
    Stringer, M.
    Longmate, J.
    Keeling, J.
    Kirby, J.
    Smithson, J.
    Robson, K.
    Scutt, P.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (SUPP 3) : 233 - 233
  • [4] The Tranexamic Acid for Intracerebral Haemorrhage-2 (TICH-2) Trial: Results of One Year Follow Up Data
    Law, Zhe Kang
    Scutt, Polly
    Woodhouse, Lisa J.
    Gray, Robert
    Appleton, Jason P.
    Lysons, Christopher
    Frowd, Nadia
    Bath, Philip M.
    Sprigg, Nikola
    STROKE, 2019, 50
  • [5] Statistical analysis plan for the ‘Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage’ (TICH-2) trial
    Katie Flaherty
    Philip M. Bath
    Robert Dineen
    Zhe Law
    Polly Scutt
    Stuart Pocock
    Nikola Sprigg
    Trials, 18
  • [6] Statistical analysis plan for the 'Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage' (TICH-2) trial
    Flaherty, Katie
    Bath, Philip M.
    Dineen, Robert
    Law, Zhe
    Scutt, Polly
    Pocock, Stuart
    Sprigg, Nikola
    TRIALS, 2017, 18
  • [7] EFFECT OF PRIOR ANTIPLATELET THERAPY ON HAEMATOMA CHARACTERISTICS AND FUNCTIONAL OUTCOME: A SUBGROUP ANALYSIS OF THE TRANEXAMIC ACID IN INTRACEREBRAL HAEMORRHAGE-2 (TICH-2) TRIAL
    Law, Z. K.
    Flaherty, K.
    Scutt, P.
    Appleton, J.
    Bath, P.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 4 - 5
  • [8] TICH-2 trial - Tranexamic acid for intracerebral hemorrhage 2
    Sprigg, N.
    Bath, P. M. W.
    Krishnan, K.
    Utton, S.
    Foster, H.
    Payne, T.
    Adrian, M.
    Grant, S.
    Durham, A.
    Robson, K.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 253 - 253
  • [9] Neurosurgical intervention after intracerebral haemorrhage: data from the Tranexamic acid for Intracerebral Haemorrhage 2 (TICH-2) Trial
    Hollingworth, M.
    Woodhouse, L.
    Law, Z. K.
    Munshi, S.
    Krishan, K.
    Bath, P. M.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (4_SUPPL) : 26 - 27
  • [10] Baseline characteristics of patients enrolled in the tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH 2) study
    Robson, K.
    Sprigg, N.
    Krishnan, K.
    Bath, P.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 14 - 14
12345